Innovation
2 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 53 times.
| Year | Filings |
|---|---|
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Investor mix
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 1 | 100% |
Manufacture of erythropoietin and developing vaccines for HIV and Cancer
2 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 53 times.
| Year | Filings |
|---|---|
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 1 | 100% |